Smith, Moore & Co. Corcept Therapeutics Inc Transaction History
Smith, Moore & Co.
- $1.03 Billion
- Q1 2025
A detailed history of Smith, Moore & Co. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Smith, Moore & Co. holds 2,867 shares of CORT stock, worth $202,324. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,867Holding current value
$202,324% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
477Shares Held
84MCall Options Held
1.43MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.17 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$704 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$546 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$434 Million1.13% of portfolio
-
Parallel Advisors, LLC3.97MShares$280 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.56B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...